Apply for Emend (Aprepitant) Copay Assistance Now

Emend (aprepitant) is an antiemetic in the substance P / neurokinin-1 (NK1) receptor antagonist class. It is used to prevent the nausea and vomiting that can come with chemotherapy, and the generic aprepitant capsule is also used to prevent nausea and vomiting after surgery. It works by blocking the NK1 receptor, and it is given alongside other antiemetics rather than on its own. Emend is meant to prevent nausea before it starts; it is not used to treat nausea that is already happening.

Aprepitant blocks the substance P / neurokinin-1 (NK1) receptor, a pathway involved in both the immediate and the delayed waves of nausea and vomiting. By targeting that receptor, it boosts the effect of the other medications it is paired with, typically a 5-HT3 receptor antagonist and a corticosteroid such as dexamethasone. This combination approach is why aprepitant is prescribed as part of a regimen.

Certain chemotherapy drugs are highly likely to cause nausea and vomiting, both in the first 24 hours and in the days that follow. Major oncology guidelines (ASCO, and MASCC/ESMO) recommend adding an NK1 receptor antagonist like aprepitant to the antiemetic plan for highly and moderately emetogenic chemotherapy. For chemotherapy prevention, the oral regimen is commonly started about one hour before treatment and continued for the next two days, always in combination with other antiemetics. Your oncology team decides the exact regimen.

Yes. Generic aprepitant capsules carry an FDA indication for the prevention of postoperative nausea and vomiting (PONV) in adults, and an intravenous form (Aponvie) is also approved for this use. Note that the PONV indication was removed from the brand Emend capsule labeling in 2019 but remains on the generic aprepitant capsule labeling. When used for surgery, the oral dose is generally taken within a few hours before anesthesia. The anesthesia and surgical team determine whether it is appropriate for a given patient and procedure.

Aprepitant is available as oral capsules (commonly 40 mg, 80 mg, and 125 mg, including bipack and tripack combinations), as an oral suspension (125 mg/5 mL, often used for patients who cannot swallow capsules, including children), and as intravenous formulations (Cinvanti and Aponvie). The right form depends on the patient and the indication. QuickRx dispenses the oral capsule and suspension forms.

The more commonly reported side effects include tiredness or fatigue, hiccups, constipation, diarrhea, loss of appetite, and headache. Most people have only mild side effects or none at all. Rarely, serious allergic (hypersensitivity) reactions can occur. This is a general summary and not a complete list; always review side effects and warnings with your prescriber or pharmacist, and seek medical help right away for signs of an allergic reaction such as rash, swelling, or trouble breathing.

Yes, aprepitant has a number of clinically important drug interactions because it affects the CYP3A4 enzyme pathway. It can interact with certain steroids (such as dexamethasone), some sedatives, certain chemotherapy agents, and other drugs. It can also reduce the effectiveness of hormonal birth control, so an additional or alternative form of contraception is advised during treatment and for one month after the last dose. Grapefruit juice and St. John’s wort should be avoided. Always have a pharmacist review your full medication list. This is exactly the kind of coordination a QuickRx pharmacist handles for you.

Yes. Generic aprepitant capsules are available and are often less expensive than brand-name Emend. In some cases the generic also carries indications (such as PONV) that are no longer on the brand capsule label. QuickRx can check whether a generic option is appropriate and covered under your plan, which is frequently one of the simplest ways to lower your cost.

Emend is a specialty antiemetic, and brand-name capsules, the oral suspension, and the IV forms can each be costly, with brand capsule therapy packs often running into the hundreds of dollars per course before insurance. Your actual out-of-pocket cost depends on your insurance, your deductible, and whether a generic is used. Because the price varies so much, the most useful next step is to let QuickRx run your specific situation against available copay cards and assistance programs.

Emend copay assistance refers to programs, often called copay cards, manufacturer programs, or foundation grants, that lower what you pay out of pocket. These programs can be hard to find and time-consuming to enroll in and keep active. QuickRx researches every program you may qualify for, completes the applications, handles prior authorizations, and monitors your enrollment through renewals. Our copay assistance service is always free.

Eligibility depends on the program. Manufacturer copay cards are generally for patients with commercial (private) insurance and are not available to patients on government plans like Medicare or Medicaid. Foundation and patient assistance programs may help underinsured or government-insured patients based on income, diagnosis, and U.S. residency. Eligible patients MAY pay $0 depending on their plan and program. The fastest way to know what you qualify for is to call (917) 830-2525 and let a navigator review your situation.

Often, yes, though through a different route. Manufacturer copay cards usually exclude government insurance, but charitable foundation grants and patient assistance programs are frequently available to Medicare and Medicaid patients who meet income and diagnosis requirements. QuickRx specializes in matching patients to the right program for their coverage type.

Yes. QuickRx is licensed in all 50 states and coordinates nationwide delivery, including the handling required for temperature-sensitive specialty medications. We work to keep refills on schedule so therapy is not interrupted.

Call (917) 830-2525 or fill out the form on this page. A QuickRx patient navigator will reach out within one business day to review your prescription and insurance and begin identifying assistance programs you may qualify for. There is no cost for this service.